---
title: 2024 update of the AGIHO guideline on diagnosis and empirical treatment of
  fever of unknown origin (FUO) in adult neutropenic patients with solid tumours and
  hematological malignancies
date: '2025-02-20'
linkTitle: https://pubmed.ncbi.nlm.nih.gov/39973942/?utm_source=curl&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1FakS-2QOkCT8HsMOQP1bCRQ4YzyumYOmxmF0moLsQ3dFB1E9V&fc=20220326224207&ff=20250220170953&v=2.18.0.post9+e462414
source: heidelberg[Affiliation]
description: Febrile Neutropenia is an emergency in the treatment of cancer patients.
  It requires prompt and evidence-based clinical and antimicrobial management. The
  implementation of standard operating procedures (SOP) across hospitals and outpatient
  cancer departments can improve the outcome of FN patients by reducing FN-related
  morbidity and mortality and by the continuation of cancer treatment. This guideline
  describes an evidence-based approach to risk stratification, epidemiology, diagnosis,
  ...
disable_comments: true
---
Febrile Neutropenia is an emergency in the treatment of cancer patients. It requires prompt and evidence-based clinical and antimicrobial management. The implementation of standard operating procedures (SOP) across hospitals and outpatient cancer departments can improve the outcome of FN patients by reducing FN-related morbidity and mortality and by the continuation of cancer treatment. This guideline describes an evidence-based approach to risk stratification, epidemiology, diagnosis, ...